Longwood
HMS Is Facing a Deficit. Under Trump, Some Fear It May Get Worse.
Harvard Medical School administrators and professors are already worried about the school’s tightening budget and declining federal research funds. Trump’s reelection adds a whole new level of risk.
Beth Israel Medical Center Residents and Physicians File for Unionization
Beth Israel Deaconess Medical Center residents and physicians filed for unionization last Thursday with the National Labor Relations Board.
HMS Study Reveals How Mutation Can Accelerate Breast Cancer Progression
A new study led by Harvard Medical School researchers shed new light on how even a single defective copy of the tumor-suppressor BRCA1 gene can increase patients’ risk of developing breast cancer.
HMS Study Suggests New Narratives for Pompeii Victims
New DNA analysis challenges existing hypotheses about the identities and relationships of victims found in Pompeii after the eruption of Mount Vesuvius in 79 C.E., per a study published in Current Biology on Nov. 7.
Harvard Medical School Alums Donate $6 Million for AI Health Care Education
The Dunleavy Foundation, led by Harvard Medical School alum Keith R. Dunleavy, gave HMS $6 million to expand educational opportunities for leveraging artificial intelligence in health care.
Ozempic, Wegovy Use Doubled as Bariatric Surgery Procedures Declined in 2022-2023, Harvard Researchers Report
The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by about 25 percent from 2022 to 2023, researchers report in an Oct. 25 study.
Harvard Study Suggests Vitamin D Has No Effect on Cardiovascular Health
Vitamin D supplementation does not reduce the risk of cardiovascular disease, researchers reported in a September paper.
Harvard Medical School Receives Federal Warning Over Animal Welfare Violation
The U.S. Department of Agriculture issued an official warning notice that Harvard Medical School researchers violated federal animal welfare laws after the school self-reported the incident.
Harvard Dental School to Run Deficit, Dean Confident in Mending Donor Relations
Harvard School of Dental Medicine Dean William V. Giannobile said the school will run a deficit this year but expressed confidence in his ability to mend fractured donor relationships in a Wednesday interview with The Crimson, his first in three years.
‘Play, Read, Vote’: Panelists Discuss Election Anxiety at Harvard Public Health School
Political analysts, public health officials, and pollsters discussed navigating election anxiety at a panel at the Harvard School of Public Health on Tuesday.
Harvard Dental School Dean Wins American Dental Association Award for Research
Harvard School of Dental Medicine Dean William V. Giannobile was presented with the American Dental Association’s 2024 Gold Medal Award for Excellence in Dental Research last Friday.
AI Is Changing Healthcare. Harvard Medical School Is Following Suit.
The Harvard Medical School started offering a month-long introductory course on AI in healthcare for students on its Health Sciences and Technology track — the first of its kind offered at a medical school.
Brigham and Women’s Research Examines Potential Causes of Long Covid-19
Researchers at the Harvard-affiliated Brigham and Women’s Hospital found that the Covid-19 antigen is twice as likely to be present in patients suffering from long Covid-19 compared to their asymptomatic counterparts.
Brigham and Women's Hospital Researchers Find Nasal Spray Protects Against Respiratory Illnesses
Researchers found that a drug-free nasal spray protected against airborne respiratory illnesses — including Covid-19, influenza, viruses, and pneumonia — in a preclinical study published by Harvard Medical School-affiliated Brigham and Women’s Hospital on Sept. 24.
Canadian Biotech Company to Supply MDMA for McLean Hospital Clinical Trial
Toronto-based MDMA manufacturer PharmAla Biotech signed a contract to supply researchers at McLean Hospital, an HMS-affiliated psychiatric teaching hospital, with the drug for a pending clinical trial, PharmAla announced in a Oct. 2 press release.
